EAI Trademark

Trademark Overview


On Monday, August 7, 2023, a trademark application was filed for EAI with the United States Patent and Trademark Office. The USPTO has given the EAI trademark a serial number of 98120597. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, December 3, 2024. This trademark is owned by Delphi Diagnostics, Inc.. The EAI trademark is filed in the Pharmaceutical Products category with the following description:

Clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for testing biopsy and other tissue samples for use in disease detection, namely, breast cancer; clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for breast cancer surveillance, namely, for measuring amounts of genomic and other biomarkers contacted with the reagent, such as estrogen receptor (ER), progesterone receptor (PR) associated biomarkers, and other suitable biomarkers for monitoring breast cancer occurrence, recurrence, response to various chemotherapies, hormone therapies, radiation therapies, or other suitable treatments
eai

General Information


Serial Number98120597
Word MarkEAI
Filing DateMonday, August 7, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, December 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2024

Trademark Statements


Goods and ServicesClinical diagnostic testing kits comprised of medical diagnostic reagents and assays for testing biopsy and other tissue samples for use in disease detection, namely, breast cancer; clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for breast cancer surveillance, namely, for measuring amounts of genomic and other biomarkers contacted with the reagent, such as estrogen receptor (ER), progesterone receptor (PR) associated biomarkers, and other suitable biomarkers for monitoring breast cancer occurrence, recurrence, response to various chemotherapies, hormone therapies, radiation therapies, or other suitable treatments

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDelphi Diagnostics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77055

Party NameDelphi Diagnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77055

Trademark Events


Event DateEvent Description
Monday, February 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 10, 2023NEW APPLICATION ENTERED
Wednesday, September 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 8, 2024ASSIGNED TO EXAMINER
Friday, April 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 11, 2024NON-FINAL ACTION WRITTEN
Thursday, April 11, 2024NON-FINAL ACTION E-MAILED
Thursday, April 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 20, 2024FINAL REFUSAL WRITTEN
Saturday, April 20, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, April 20, 2024FINAL REFUSAL E-MAILED
Tuesday, April 23, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, September 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 12, 2024ASSIGNED TO LIE
Wednesday, October 2, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 22, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT